A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.
List details
Basic info
Status | Submitted |
---|---|
Submitter | Finland |
Submitter email | CLH_Proposals@tukes.fi |
Regulatory programme |
|
CLP Annex VI Index Number |
|
Classification
Harmonised classification at the time of the proposal |
|
---|---|
Proposed harmonised classification by the dossier submitter |
|
Proposed specific concentration limits by the dossier submitter | Oral: ATE = 500 mg/kg bw |
Intention timeline
Date of intention | 2019-12-31 |
---|---|
Expected date of submission | 2020-06-12 |
Submitted for accordance check | 2020-06-23 |
Documents
Related substances
By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.
Related regulatory records
Record history
The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.
Dec. 8, 2020
- CLH report: https://echa.europa.eu/documents/10162/40b187db-f4f2-74f8-01b2-90828c6590f3
- Deadline for commenting: 2021-02-05
- Final submission date: 2020-11-06
- Hazard classes open for commenting: Acute toxicity Skin sensitisation Specific target organ toxicity — single exposure Aquatic acute 1
- Legal deadline for opinion adoption: 2022-05-08
- Status: Submitted → Consultation
- Start of consultation: 2020-12-07
Feb. 16, 2021
- Comments received: https://echa.europa.eu/documents/10162/35c98f91-4cd0-cdde-c16c-e06bba82fde2
- Public consultations - received attachments: https://echa.europa.eu/documents/10162/80d36208-86e3-bf4d-828b-b753893630d6
- Status: Consultation → Opinion Development
March 31, 2021
- Name: resorcinol; 1,3-benzenediol → 1,3-benzenediol;resorcinol
April 8, 2021
- Name: 1,3-benzenediol;resorcinol → resorcinol; 1,3-benzenediol
Oct. 8, 2021
- Date of opinion: 2021-09-16
- Status: Opinion Development → Opinion Adopted
Jan. 6, 2022
- Background document: https://echa.europa.eu/documents/10162/22cdee1c-bdce-5766-a09c-a3fe58c406a6
- Comments received: https://echa.europa.eu/documents/10162/35c98f91-4cd0-cdde-c16c-e06bba82fde2 → https://echa.europa.eu/documents/10162/d016db3f-f51d-8eee-5b37-904f4e4cd7d0
- RAC opinion: https://echa.europa.eu/documents/10162/69438db0-e4f0-c44d-199d-3ce4ced21413
Jan. 18, 2022
- RAC opinion: https://echa.europa.eu/documents/10162/69438db0-e4f0-c44d-199d-3ce4ced21413 → https://echa.europa.eu/documents/10162/7689dcc4-8225-9f10-5889-69378b211c36
This version
Nov. 11, 2020
- Proposed harmonised classification by the dossier submitter: Aquatic Acute 1, M-factor=1
July 14, 2020
- Proposed harmonised classification by the dossier submitter: STOT SE 1, H370
- Proposed harmonised classification by the dossier submitter: Skin Sens. 1A, H317
- Proposed specific concentration limits by the dossier submitter: Oral: ATE = 500 mg/kg bw
- Status: Intention → Submitted
- Submitted for accordance check: 2020-06-23
- Submitter email: CLH_Proposals@tukes.fi
Feb. 27, 2020
- Name: Resorcinol → resorcinol; 1,3-benzenediol
Add the related substance to your watchlist to monitor this regulatory record.